Pemazyre Tablet
Product Images NDC 50881-026

4 FDA label images from Incyte Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pemazyre (NDC 50881-026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Incyte Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Pemazyre 1)

Chemical Structure (Pemazyre 1)
Chemical structure diagram of pemigatinib, the active ingredient in PEMAZYRE tablets by Incyte Corporation.*
FDA Label Image

Pemazyre (pemigatinib) 4.5mg Tablets (14 Tablet Bottle Label)

Pemazyre (pemigatinib) 4.5mg Tablets (14 Tablet Bottle Label)
PEMAZYRE (pemigatinib) tablets 4.5 mg label displaying Incyte Corporation as the manufacturer. The label includes dosing and storage instructions, a quantity of 14 tablets, an NDC number 50881-026-01, and a barcode. Additional serialization details like GTIN, serial number, lot, and expiration date are noted on a pink panel.*
FDA Label Image

Pemazyre (pemigatinib) 9mg Tablets (14 Tablet Bottle Label)

Pemazyre (pemigatinib) 9mg Tablets (14 Tablet Bottle Label)
PEMAZYRE 9 mg tablets packaging label containing 14 tablets by Incyte Corporation. The label includes prescribing dosage instructions, storage conditions at room temperature 20°C to 25°C with allowable excursions between 15°C and 30°C, and cautions to keep out of reach of children. It displays the product NDC 50881-027-01 and barcodes, along with placeholder fields for GTIN, serial number, lot number, and expiration date.*
FDA Label Image

Pemazyre (pemigatinib) 13.5mg Tablets (14 Tablet Bottle Label)

Pemazyre (pemigatinib) 13.5mg Tablets (14 Tablet Bottle Label)
Label for Pemazyre (pemigatinib) tablets, 13.5 mg strength, in a package of 14 tablets. The label indicates oral dosage form and includes storage instructions, contact information for Incyte Corporation, and warnings to keep out of reach of children. The label features the NDC 50881-028-01 and a pink section showing barcode and lot information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.